What is Finerenone?

Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) prescribed for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes (T2D). It works by blocking mineralocorticoid receptors, helping to reduce kidney inflammation and fibrosis, slowing down the progression of kidney damage.

Key Benefits of Finerenone

• Slows the progression of chronic kidney disease in diabetic patients.
• Reduces the risk of cardiovascular events, including heart failure and heart attack.
• Provides kidney protection by reducing inflammation and scarring.

Finerenone Tablet Uses

• Chronic Kidney Disease (CKD) in adults with type 2 diabetes.
• Helps manage proteinuria (excess protein in urine).
• Reduces the risk of kidney failure and need for dialysis.
• Supports cardiovascular health by lowering risks of heart complications.

Finerenone Side Effects

While Finerenone is generally well-tolerated, some patients may experience:

• Increased potassium levels (hyperkalemia)
• Dizziness or lightheadedness
• Low blood pressure (hypotension)
• Diarrhea
• Nausea

FAQs – Finerenone Tablets

What is Finerenone used for?

Finerenone is used to treat chronic kidney disease in patients with type 2 diabetes, helping to protect kidney function and reduce cardiovascular risks.

Can I buy Finerenone Tablets in the Philippines?

Yes, Finerenone (including Kerendia) is available through RxLane, with delivery to Manila, Cebu, Davao, and all regions in the Philippines.

Is Finerenone safe for all diabetic patients?

Finerenone is specifically for patients with type 2 diabetes and CKD. Your doctor will check your potassium levels before prescribing it.

Disclaimer

RxLane provides information for educational purposes only. All trademarks, brands, and service marks are the property of their respective owners. RxLane does not offer medical advice. Please consult your doctor for appropriate diagnosis and treatment. This content is intended for wholesalers, doctors, hospitals, clinics, pharmacies, and medical institutions.